Although some studies had shown that altered levels of plasma SP-D early in the course of ARDS are associated with worse clinical outcomes [7, 20], a more recent and larger study seemed to contradict those findings [11]. The gene discussed is SFTPD; the disease is acute respiratory distress syndrome.